Not Tagged
Not Tagged
[]
results from spyral htn-on med trial: primary safety endpoint met with low incidence of aes. primary efficacy endpoint not met for 24hr systolic abpm at 6 mths #aha22 download full slideset here: 
Non-Profit Founder/Leader | ?? Doc | Artist | Scientist | Educator | News Anchor https://t.co/usmuA3tKft | RT ? endorse | Disclaimer: https://t.co/bwmE2O3U5W